Gabexate: Difference between revisions

Gabexate
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Newer edit →

Revision as of 03:30, 13 February 2025

A synthetic protease inhibitor used in medical treatments

Gabexate is a synthetic protease inhibitor used primarily in the treatment of acute pancreatitis and disseminated intravascular coagulation (DIC). It functions by inhibiting the activity of proteases, which are enzymes that break down proteins, thereby reducing inflammation and other symptoms associated with these conditions.

Mechanism of Action

Gabexate works by inhibiting the activity of several serine proteases, including trypsin, kallikrein, and plasmin. By blocking these enzymes, gabexate reduces the inflammatory response and prevents the degradation of proteins that can lead to tissue damage.

Clinical Uses

Gabexate is primarily used in the management of:

Acute Pancreatitis: Gabexate is administered to reduce the inflammatory response and prevent further pancreatic damage.
Disseminated Intravascular Coagulation (DIC): It helps in managing the coagulation abnormalities by inhibiting the proteases involved in the coagulation cascade.

Administration

Gabexate is typically administered intravenously due to its rapid metabolism and short half-life. The dosage and duration of treatment depend on the severity of the condition being treated.

Side Effects

Common side effects of gabexate include:

Pharmacokinetics

Gabexate is rapidly metabolized in the body, with a short half-life of approximately 1 to 2 minutes. It is hydrolyzed by plasma esterases into inactive metabolites, which are then excreted in the urine.

Related pages

@@ Line 1: / Line 1: @@
-'''Gabexate''' is a synthetic [[anticoagulant]] with antithrombotic properties used primarily in the treatment of [[pancreatitis]] and disseminated intravascular coagulation (DIC). It is a potent inhibitor of various [[enzyme]]s involved in the coagulation process, including [[trypsin]], [[kallikrein]], [[plasmin]], and [[thrombin]]. Gabexate works by interfering with the [[enzyme]]s that contribute to the formation of blood clots and inflammation, thereby helping to manage conditions associated with excessive clotting and inflammation.
+{{Short description|A synthetic protease inhibitor used in medical treatments}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Gabexate.svg
+| image_size = 200px
+| image_alt = Structural formula of Gabexate
+}}
-== Mechanism of Action ==
+'''Gabexate''' is a [[synthetic]] [[protease inhibitor]] used primarily in the treatment of [[acute pancreatitis]] and [[disseminated intravascular coagulation]] (DIC). It functions by inhibiting the activity of [[proteases]], which are enzymes that break down proteins, thereby reducing inflammation and other symptoms associated with these conditions.
-Gabexate mesilate, the mesilate salt of gabexate, functions by inhibiting the activity of serine proteases, which are a group of enzymes that play a crucial role in coagulation and inflammatory processes. By blocking these enzymes, gabexate reduces the formation of blood clots and mitigates inflammation, making it effective in treating conditions like acute pancreatitis, where inflammation is a significant concern, and DIC, where abnormal clotting is observed.
-== Clinical Uses ==
+==Mechanism of Action==
+Gabexate works by inhibiting the activity of several [[serine proteases]], including [[trypsin]], [[kallikrein]], and [[plasmin]]. By blocking these enzymes, gabexate reduces the inflammatory response and prevents the degradation of proteins that can lead to tissue damage.
+==Clinical Uses==
 Gabexate is primarily used in the management of:
-* Acute [[pancreatitis]] - to reduce inflammation and prevent complications.
-* Disseminated intravascular coagulation (DIC) - to control excessive clot formation.
-It may also be used in certain cases to prevent complications during procedures that carry a high risk of triggering blood clot formation.
-== Pharmacokinetics ==
+* '''Acute Pancreatitis''': Gabexate is administered to reduce the inflammatory response and prevent further pancreatic damage.
-Gabexate is usually administered intravenously due to its poor absorption when taken orally. The drug is rapidly distributed in the body and is known to have a short half-life, necessitating continuous infusion for sustained therapeutic effect in some cases.
+* '''Disseminated Intravascular Coagulation (DIC)''': It helps in managing the coagulation abnormalities by inhibiting the proteases involved in the coagulation cascade.
+==Administration==
+Gabexate is typically administered intravenously due to its rapid metabolism and short half-life. The dosage and duration of treatment depend on the severity of the condition being treated.
-== Side Effects ==
+==Side Effects==
-While gabexate is generally well-tolerated, some patients may experience side effects such as:
+Common side effects of gabexate include:
-* Nausea
-* Vomiting
-* Hypotension (low blood pressure)
-* Skin rash
-Severe allergic reactions are rare but can occur, especially in individuals with a known allergy to gabexate or any of its components.
-== Contraindications ==
+* [[Hypotension]]
-Gabexate should be used with caution in patients with:
+* [[Nausea]]
-* Known hypersensitivity to gabexate or any component of the formulation.
+* [[Allergic reactions]]
-* Severe kidney impairment, as the drug is excreted primarily by the kidneys.
-== Conclusion ==
+==Pharmacokinetics==
-Gabexate is a valuable drug in the management of conditions associated with excessive clotting and inflammation, such as pancreatitis and DIC. Its ability to inhibit a wide range of serine proteases makes it effective in controlling the complex processes involved in these conditions. However, like all medications, it must be used judiciously, considering its side effects and contraindications.
+Gabexate is rapidly metabolized in the body, with a short half-life of approximately 1 to 2 minutes. It is hydrolyzed by plasma esterases into inactive metabolites, which are then excreted in the urine.
-[[Category:Anticoagulants]]
+==Related pages==
-[[Category:Pharmacology]]
+* [[Protease inhibitor]]
+* [[Acute pancreatitis]]
+* [[Disseminated intravascular coagulation]]
-{{pharmacology-stub}}
+[[Category:Protease inhibitors]]
+[[Category:Drugs used in digestive system disorders]]